超敏C-反应蛋白与2型糖尿病肾病的关系

被引:25
作者
尤巧英
李成江
朱麒钱
斯徐伟
机构
[1] 绍兴市人民医院内分泌科
[2] 浙江大学医学院附属第一医院内分泌科
关键词
超敏C-反应蛋白; 2型糖尿病; 糖尿病肾病;
D O I
暂无
中图分类号
R587.2 [糖尿病性昏迷及其他并发症];
学科分类号
1002 ; 100201 ;
摘要
目的 探讨C -反应蛋白(CRP)与不同时期糖尿病肾病的关系。方法 采用颗粒增强免疫法测定超敏CRP(usCRP)。根据尿白蛋白排泄率(UAER)将1 0 4例2型糖尿病患者分为正常蛋白尿组(48例)、微量白蛋白尿组(30例)、临床蛋白尿组(2 6例)。另选30例作为正常对照组。观察各组血清usCRP水平。结果 2型糖尿病各组血清usCRP水平较正常对照组明显升高,且usCRP水平随白蛋白尿的增加而升高;在2型糖尿病病人中,Person相关分析显示usCRP与UAER(r =0 .6 0 7,P =0 .0 0 0 )、甘油三酯(r =0 .4 2 3,P =0 .0 0 2 )及血肌酐(r =0 .32 2 ,P =0 .0 1 9)呈正相关,逐步线性回归结果表明,UAER、甘油三酯是影响usCRP的主要因素。结论 CRP与糖尿病肾病有关,且其水平与糖尿病肾病的程度呈一致性。
引用
收藏
页码:24 / 26
页数:3
相关论文
共 8 条
[1]  
The macroinflammatory state in uremia: causes and potential consequences. Kaysen GA. Journal of the American Society of Nephrology . 2001
[2]  
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. Ridker PM,Hennekens CH,Buring JE,et al. The New England Journal of Medicine . 2000
[3]  
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Ridker PM. Circulation . 2001
[4]  
Diabetes[P]. 英国专利:GB201117172D0,2011-11-16
[5]  
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[6]  
C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Devaraj S,Xu DY,Jialal I. Circulation . 2003
[7]  
C- reactive protein in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction: Potential role for cytokines originating from adipose tissue. Yudkin JS,Stehouwer CDA,Emeis JJ,et al. Arteriosclerosis and Thrombosis . 1999
[8]  
Von Willebrand factor, C-reactive protein and 5-year mortality in diabetic and nondiabetic subjects: the Hoon Study. Jager A,van Hinsbergh VWM,Kostense PJ,et al. Arteriosclerosis and Thrombosis . 1999